Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -5271.69% is 48% below its 5-year average of -3569.29%, near the high end of its 5-year range (-75787.10%–0.00%).
18.17% above its 12-month average of -6442.57%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -6649.26%.
OPERATING MARGIN
-5271.69%
OPERATING MARGIN AVG TTM
-6442.57%
OPERATING MARGIN AVG 3Y
-2852.75%
OPERATING MARGIN AVG 5Y
-3569.29%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+18.17%
CURRENT VS 3Y AVG
-84.79%
CURRENT VS 5Y AVG
-47.70%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Humacyte, Inc.
Market Cap
$80.88M
Operating Margin
-5271.69%
TTM Avg
-6442.57%
3Y Avg
-2852.75%
5Y Avg
-3569.29%
Market Cap
$81.38M
Operating Margin
-408.41%
TTM Avg
-360.51%
3Y Avg
-288.53%
5Y Avg
-284.25%
Market Cap
$81.79M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-70860.78%
Market Cap
$82.47M
Operating Margin
-42.06%
TTM Avg
-31.00%
3Y Avg
-37.02%
5Y Avg
-45.87%
Market Cap
$79.61M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$83.82M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$82.47M
Operating Margin
-8256.32%
TTM Avg
-7689.73%
3Y Avg
-8755.63%
5Y Avg
-8045.81%
Market Cap
$78.44M
Operating Margin
0.00%
TTM Avg
-1188.79%
3Y Avg
-873.63%
5Y Avg
-703.36%
Market Cap
$83.18M
Operating Margin
-3242.47%
TTM Avg
-1621.23%
3Y Avg
-1058.13%
5Y Avg
-747.59%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Humacyte, Inc. (HUMA) | $80.88M | -5271.69% | -6442.57% | -2852.75% | -3569.29% |
| Nutriband Inc. (NTRB)vs › | $81.38M | -408.41% | -360.51% | -288.53% | -284.25% |
| ProMIS Neurosciences, Inc. (PMN)vs › | $81.79M | 0.00% | 0.00% | 0.00% | -70860.78% |
| LENSAR Inc (LNSR)vs › | $82.47M | -42.06% | -31.00% | -37.02% | -45.87% |
| Acrivon Therapeutics, Inc. Common Stock (ACRV)vs › | $79.61M | 0.00% | 0.00% | 0.00% | 0.00% |
| Telomir Pharmaceuticals, Inc. Common Stock (TELO)vs › | $83.82M | 0.00% | 0.00% | 0.00% | 0.00% |
| Cardiff Oncology, Inc. (CRDF)vs › | $82.47M | -8256.32% | -7689.73% | -8755.63% | -8045.81% |
| vTv Therapeutics Inc. (VTVT)vs › | $78.44M | 0.00% | -1188.79% | -873.63% | -703.36% |
| MediciNova, Inc. (MNOV)vs › | $83.18M | -3242.47% | -1621.23% | -1058.13% | -747.59% |
| Inovio Pharmaceuticals, Inc. (INO)vs › | $78.07M | -132871.32% | -92244.12% | -51098.97% | -37173.74% |
Gross Margin
-736.5%
Operating Margin
-5271.7%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -6649.26% |
| 2026-03-31 | -5845.45% |
| 2025-12-31 | -6603.00% |
| 2025-09-30 | -3239.04% |
| 2025-06-30 | -9876.08% |
| 2025-03-31 | -4484.33% |
| 2024-12-31 | -388.60% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | -75787.10% |
| 2022-06-30 | -1424.37% |
| 2022-03-31 | -9340.34% |
| 2021-12-31 | -12218.64% |
| 2021-09-30 | -8524.07% |
| 2021-06-30 | -2792.61% |
| 2021-03-31 | -12754.19% |
| 2020-12-31 | -12638.71% |
| 2020-09-30 | -1883.26% |
| 2020-06-30 | -7246.97% |
| 2020-03-31 | -6810.20% |
| 2019-12-31 | 0.00% |
